Latest Breaking News On - கொரியன் அமைச்சகம் ஆஃப் ஆரோக்கியம் - Page 2 : comparemela.com

 E-Mail Clopidogrel outperformed aspirin in what is believed to be the first and largest randomized trial to compare the effectiveness of the two antiplatelet drugs as long-term maintenance therapy for patients who had no adverse events after one year of dual antiplatelet therapy (DAPT) following the insertion of a coronary stent. After two years of follow-up, chronic maintenance therapy with clopidogrel resulted in a 30% reduction in deaths, heart attacks, strokes or major bleeding events, according to research presented at the American College of Cardiology s 70th Annual Scientific Session. These data confirm our working hypothesis that long-term maintenance antiplatelet monotherapy with clopidogrel produces better outcomes than aspirin in patients who are adverse event-free at one year after coronary stenting, said Hyo-Soo Kim, MD, PhD, professor of internal medicine at Seoul National University Hospital in South Korea and lead author of the study.

Soult ukpyolsiSouth koreaHyo soo kimNicole napoliYann nguyenAntiplatelet monotherapySeoul national university hospitalAmerican college of cardiologyKorean ministry of healthAmerican collegeAnnual scientificSouth korean ministryHost exam randomized controlled trialதெற்கு கொரியாஹயோ சூ கிம்நிக்கோல் ந்யாபலீ